| abstract |
"Substituted 2,3-dihydroimidazo [1,2-c] quinazoline derivatives useful for treating angiogenesis-associated hyperproliferative disorders and disorders, and pharmaceutical compositions." This invention relates to novel 2,3-dihydroimidazo [1,2-c] quinazoline compounds, pharmaceutical compositions containing such compounds and the use of those compounds or compositions for inhibiting phosphotidylinositol 3-kinase (pi3k) and treating diseases associated with Phosphotidylinositol-3-kinase (pi3k) activity, in particular treating hyperproliferative and / or angiogenesis disorders, as a sole agent or in combination with other active ingredients. |